van Moorsel CHM - Search Results

1

Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis.

Jacob J, Bartholmai BJ, van Moorsel CHM, Rajagopalan S, Devaraj A, van Es HW, Moua T, van Beek FT, Clay R, Veltkamp M, Kokosi M, de Lauretis A, Judge EP, Jacob TM, Peikert T, Karwoski R, Maldonado F, Renzoni E, Maher TM, Altmann A, Wells AU. Jacob J, et al. Among authors: van moorsel chm, van beek ft, van es hw. Eur Respir J. 2019 Sep 30;54(3):1802341. doi: 10.1183/13993003.02341-2018. Print 2019 Sep. Eur Respir J. 2019. PMID: 31196945 Free PMC article.

2

Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

Veltkamp M, Grutters JC, van Moorsel CH, Ruven HJ, van den Bosch JM. Veltkamp M, et al. Clin Exp Immunol. 2006 Aug;145(2):215-8. doi: 10.1111/j.1365-2249.2006.03127.x. Clin Exp Immunol. 2006. PMID: 16879239 Free PMC article.

3

Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.

Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, Wells AU, Tzouvelekis A, van Moorsel CH, van den Bosch JM, du Bois RM, Welsh KI. Spagnolo P, et al. Tissue Antigens. 2007 Sep;70(3):219-27. doi: 10.1111/j.1399-0039.2007.00879.x. Tissue Antigens. 2007. PMID: 17661910

4

Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis.

Barlo NP, van Moorsel CH, Ruven HJ, Zanen P, van den Bosch JM, Grutters JC. Barlo NP, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):155-61. Sarcoidosis Vasc Diffuse Lung Dis. 2009. PMID: 20560296

5

Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort.

van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, Ruven HJ, van Es HW, van den Bosch JM, Grutters JC. van Moorsel CH, et al. Am J Respir Crit Care Med. 2010 Dec 1;182(11):1419-25. doi: 10.1164/rccm.200906-0953OC. Epub 2010 Jul 23. Am J Respir Crit Care Med. 2010. PMID: 20656946

6

Toll-like receptor (TLR)-9 genetics and function in sarcoidosis.

Veltkamp M, Van Moorsel CH, Rijkers GT, Ruven HJ, Van Den Bosch JM, Grutters JC. Veltkamp M, et al. Clin Exp Immunol. 2010 Oct;162(1):68-74. doi: 10.1111/j.1365-2249.2010.04205.x. Epub 2010 Aug 19. Clin Exp Immunol. 2010. PMID: 20659127 Free PMC article.

7

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.

Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, Heron M, van den Bosch JM, Grutters JC. Korthagen NM, et al. Respir Med. 2011 Jan;105(1):106-13. doi: 10.1016/j.rmed.2010.09.012. Respir Med. 2011. PMID: 20888745 Free article.

8

Predicting prognosis in idiopathic pulmonary fibrosis.

Barlo NP, van Moorsel CH, van den Bosch JM, Grutters JC. Barlo NP, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):85-95. Sarcoidosis Vasc Diffuse Lung Dis. 2010. PMID: 21319590 Review.

9

Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.

Veltkamp M, van Moorsel CH, Rijkers GT, Ruven HJ, Grutters JC. Veltkamp M, et al. Tissue Antigens. 2012 Jan;79(1):25-32. doi: 10.1111/j.1399-0039.2011.01808.x. Tissue Antigens. 2012. PMID: 22150367 Clinical Trial.

10

Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M, Thomeer M, van Moorsel CHM, Grutters JC. Vorselaars ADM, et al. Among authors: van moorsel chm. Chest. 2013 Sep;144(3):805-812. doi: 10.1378/chest.12-1728. Chest. 2013. PMID: 23538719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page